+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asia-Pacific and Latin America Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Type, Molecule Type, Services, Therapeutic Areas, Region, and Segment Forecasts, 2026-2033- Product Image
Asia-Pacific and Latin America Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Type, Molecule Type, Services, Therapeutic Areas, Region, and Segment Forecasts, 2026-2033- Product Image
New

Asia-Pacific and Latin America Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Type, Molecule Type, Services, Therapeutic Areas, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • February 2026
  • Region: Asia Pacific, Latin America
  • Grand View Research
  • ID: 6227933
REQUEST CUSTOMIZATION
Description Jump to:
The Asia Pacific and Latin America pharmaceutical contract manufacturing market size was valued at USD 21.56 billion in 2025 and is projected to reach USD 40.71 billion by 2033, growing at a CAGR of 8.39% from 2026 to 2033. The industry is driven by the growing number of generic drug approvals, growing clinical and commercial emphasis on biologic medicines and their biosimilar counterparts, and a strengthening regulatory framework.

The growing number of generic drug approvals is driving significant demand for high-volume manufacturing and remains a major structural driver of the Asia Pacific and Latin America pharmaceutical contract manufacturing market. According to the U.S. FDA Office of Generic Drugs, the agency approved 956 abbreviated new drug applications (ANDAs) in 2023 and 694 ANDAs in 2024, reflecting robust development activity in the global generic drug space.

A significant portion of the global pharmaceutical supply chain is concentrated in India and China, where India accounts for approximately 48% of all active pharmaceutical ingredient (API) Drug Master Files (DMFs) and China contributes 18%. Latin America is emerging as a key regional production hub, supported by favorable government policies and investments in local manufacturing capacity. This concentration enables pharmaceutical companies to leverage cost-efficient, scalable, and compliant production solutions, meeting growing global demand while reducing time-to-market pressures. The combination of rising approvals and concentrated manufacturing capacity ensures sustained outsourcing activity in these high-growth regions.

Asia Pacific And Latin America Pharmaceutical Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Asia Pacific and Latin America pharmaceutical contract manufacturing market report based on type, molecule type, services, therapeutic area, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Drug Discovery
  • Pre-Clinical
  • Clinical

Molecule Type Outlook (Revenue, USD Million, 2021-2033)

  • Small Molecules
  • Large Molecules

Services Outlook (Revenue, USD Million, 2021-2033)

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others

Therapeutic Areas Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • CNS Disorders
  • Infectious Diseases
  • Immunological Disorders
  • Cardiovascular Disease
  • Respiratory Diseases
  • Diabetes
  • Ophthalmology
  • Pain Management
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • Asia Pacific
  • Latin America

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Value chain-based analysis (Model 2)
1.7.3. Multivariate Analysis (Model 3)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Landscape Insights
Chapter 3. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunities
3.3. Technological Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Supply Chain Analysis
3.7. Market Analysis Tools
3.7.1. Porter’s Five Forces Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Type Movement Analysis
4.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Pre-clinical
4.4.1. Drug Discovery Market Estimates and Forecasts, 2021-2033 (USD million)
4.5. Drug Discovery
4.5.1. Pre-Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Target Validation
4.5.2.1. Target Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Lead Identification
4.5.3.1. Lead Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.4. Lead Optimization
4.5.4.1. Lead Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Clinical
4.6.1. Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.2. Phase I Trial Services
4.6.2.1. Phase I Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.3. Phase II Trial Services
4.6.3.1. Phase II Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.4. Phase III Trial Services
4.6.4.1. Phase III Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.5. Phase IV Trial Services
4.6.5.1. Phase IV Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Molecule Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Molecule Type Movement Analysis
5.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Molecule Type, 2021 to 2033 (USD Million)
5.4. Small Molecules
5.4.1. Small Molecules Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Large Molecules
5.5.1. Large Molecules Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Services Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Services Movement Analysis
6.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Services, 2021 to 2033 (USD Million)
6.4. Project Management/Clinical Supply Management
6.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Data Management
6.5.1. Data Management Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Regulatory/Medical Affairs
6.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Medical Writing
6.7.1. Medical Writing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Clinical Monitoring
6.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Quality Management/ Assurance
6.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021-2033 (USD Million)
6.10. Bio-statistics
6.10.1. Bio-statistics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.11. Investigator Payments
6.11.1. Investigator Payments Market Estimates and Forecasts, 2021-2033 (USD Million)
6.12. Laboratory
6.12.1. Laboratory Market Estimates and Forecasts, 2021-2033 (USD Million)
6.13. Patient And Site Recruitment
6.13.1. Patient And Site Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.14. Technology
6.14.1. Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
6.15. Others
6.15.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Therapeutic Areas Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Therapeutic Areas Movement Analysis
7.3. Asia and Latin America Pharmaceutical Contract Manufacturing Market Size & Trend Analysis, by Therapeutic Areas, 2021 to 2033 (USD Million)
7.4. Oncology
7.4.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. CNS Disorders
7.5.1. CNS Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Infectious Diseases
7.6.1. Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Immunological Disorders
7.7.1. Immunological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Cardiovascular Disease
7.8.1. Cardiovascular Disease Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9. Respiratory Diseases
7.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.10. Diabetes
7.10.1. Diabetes Market Estimates and Forecasts, 2021-2033 (USD Million)
7.11. Ophthalmology
7.11.1. Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.12. Pain Management
7.12.1. Pain Management Market Estimates and Forecasts, 2021-2033 (USD Million)
7.13. Other
7.13.1. Other Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Asia and Latin America Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis by Type, Molecule Type, Services, Therapeutic Area
8.1. Regional Market Dashboard
8.2. Regional Market Snapshot
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. Asia Pacific
8.4.1. Asia Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Asia and Latin America Pharmaceutical Contract Manufacturing Market Assessment Analysis, 2025
9.3. Company Profiles
9.3.1. WuXi STA
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Piramal Pharma Solutions
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Syngene International
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Samsung Biologics
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Jubilant Pharmova
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Celltrion
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Ajinomoto Bio-Pharma Services
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Almac Group
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Rubicon Research Pvt. Ltd.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Aurigene Pharmaceutical Services
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Eurofarma Laboratórios S.A
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Service Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Unither Pharmaceuticals
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Service Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Fujifilm Diosynth Biotechnologies
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Service Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. Patheon (Thermo Fisher Scientific)
9.3.14.1. Company Overview
9.3.14.2. Financial Performance
9.3.14.3. Service Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. Pfizer
9.3.15.1. Company Overview
9.3.15.2. Financial Performance
9.3.15.3. Service Benchmarking
9.3.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 4 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 5 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 6 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 7 Asia and Latin America Pharmaceutical Contract Manufacturing Market by Region, 2021-2033 (USD Million)
Table 8 Asia Pacific Pharmaceutical Contract Manufacturing Market by Country, 2021-2033 (USD Million)
Table 9 Japan Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 10 Japan Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 11 Japan Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 12 Japan Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 13 China Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 14 China Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 15 China Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 16 China Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 17 India Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 18 India Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 19 India Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 20 India Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 21 South Korea Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 22 South Korea Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 23 South Korea Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 24 South Korea Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 25 Thailand Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 26 Thailand Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 27 Thailand Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 28 Thailand Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 29 Australia Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 30 Australia Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 31 Australia Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 32 Australia Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 33 Latin America Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 34 Latin America Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 35 Latin America Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 36 Latin America Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 37 Brazil Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 38 Brazil Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 39 Brazil Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 40 Brazil Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
Table 41 Argentina Pharmaceutical Contract Manufacturing Market by Type, 2021-2033 (USD Million)
Table 42 Argentina Pharmaceutical Contract Manufacturing Market by Molecule Type, 2021-2033 (USD Million)
Table 43 Argentina Pharmaceutical Contract Manufacturing Market by Services, 2021-2033 (USD Million)
Table 44 Argentina Pharmaceutical Contract Manufacturing Market by Therapeutic Area, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Asia and Latin America Pharmaceutical Contract Manufacturing market segmentation
Figure 3 Market research process
Figure 4 Information procurement
Figure 5 Data Analysis Models
Figure 6 Market Formulation And Validation
Figure 7 Data Validating & Publishing
Figure 8 Commodity flow analysis
Figure 9 Primary interviews in North America
Figure 10 Primary interviews in Europe
Figure 11 Primary interviews in Asia Pacific
Figure 12 Primary interviews in Latin America
Figure 13 Primary interviews in MEA
Figure 14 Market Snapshot
Figure 15 Segment Snapshot
Figure 16 Segment Snapshot
Figure 17 Competitive Landscape Snapshot
Figure 18 Parent market outlook, 2025 (USD Million)
Figure 19 Ancillary market outlook, 2025 (USD Million)
Figure 20 Current shared services and outsourcing usage levels
Figure 21 Porter’s five forces analysis
Figure 22 Asia and Latin America Pharmaceutical Contract Manufacturing market: PESTEL analysis
Figure 23 Clinical trial scenario (2022)
Figure 24 Asia and Latin America Pharmaceutical Contract Manufacturing market type outlook: Segment dashboard
Figure 25 Asia and Latin America Pharmaceutical Contract Manufacturing market, by type segment: market share, 2025 & 2033
Figure 26 Drug Discovery market, 2021-2033 (USD Million)
Figure 27 Pre-Clinical market, 2021-2033 (USD Million)
Figure 28 Clinical market, 2021-2033 (USD Million)
Figure 29 Asia and Latin America Pharmaceutical Contract Manufacturing market type outlook: Segment dashboard
Figure 30 Asia and Latin America Pharmaceutical Contract Manufacturing market, by type segment: market share, 2025 & 2033
Figure 31 Drug Discovery market, 2021-2033 (USD Million)
Figure 32 Target Validation market, 2021-2033 (USD Million)
Figure 33 Lead Identification market, 2021-2033 (USD Million)
Figure 34 Lead Optimization market, 2021-2033 (USD Million)
Figure 35 Pre-Clinical market, 2021-2033 (USD Million)
Figure 36 Clinical market, 2021-2033 (USD Million)
Figure 37 Phase I Trial Services market, 2021-2033 (USD Million)
Figure 38 Phase II Trial Services market, 2021-2033 (USD Million)
Figure 39 Phase III Trial Services market, 2021-2033 (USD Million)
Figure 40 Phase IV Trial Services market, 2021-2033 (USD Million)
Figure 41 Asia and Latin America Pharmaceutical Contract Manufacturing market molecule type outlook: Segment dashboard
Figure 42 Asia and Latin America Pharmaceutical Contract Manufacturing market, by molecule type segment: market share, 2025 & 2033
Figure 43 Small Molecules market, 2021-2033 (USD Million)
Figure 44 Large Molecules market, 2021-2033 (USD Million)
Figure 45 Asia and Latin America Pharmaceutical Contract Manufacturing market services outlook: Segment dashboard
Figure 46 Asia and Latin America Pharmaceutical Contract Manufacturing market, by services segment: market share, 2025 & 2033
Figure 47 Project Management/Clinical Supply Management market, 2021-2033 (USD Million)
Figure 48 Data Management market, 2021-2033 (USD Million)
Figure 49 Regulatory/Medical Affairs market, 2021-2033 (USD Million)
Figure 50 Medical Writing market, 2021-2033 (USD Million)
Figure 51 Clinical Monitoring market, 2021-2033 (USD Million)
Figure 52 Quality Management/ Assurance market, 2021-2033 (USD Million)
Figure 53 Bio-statistics market, 2021-2033 (USD Million)
Figure 54 Investigator Payments market, 2021-2033 (USD Million)
Figure 55 Laboratory market, 2021-2033 (USD Million)
Figure 56 Patient And Site Recruitment market, 2021-2033 (USD Million)
Figure 57 Technology market, 2021-2033 (USD Million)
Figure 58 Others market, 2021-2033 (USD Million)
Figure 59 Asia and Latin America Pharmaceutical Contract Manufacturing market therapeutic area outlook: Segment dashboard
Figure 60 Asia and Latin America Pharmaceutical Contract Manufacturing market, by therapeutic area segment: market share, 2025 & 2033
Figure 61 Oncology market, 2021-2033 (USD Million)
Figure 62 CNS Disorders market, 2021-2033 (USD Million)
Figure 63 Infectious Diseases market, 2021-2033 (USD Million)
Figure 64 Immunological Disorders market, 2021-2033 (USD Million)
Figure 65 Cardiovascular Disease market, 2021-2033 (USD Million)
Figure 66 Respiratory Diseases market, 2021-2033 (USD Million)
Figure 67 Diabetes market, 2021-2033 (USD Million)
Figure 68 Ophthalmology market, 2021-2033 (USD Million)
Figure 69 Pain Management market, 2021-2033 (USD Million)
Figure 70 Other market, 2021-2033 (USD Million)
Figure 71 Asia and Latin America Pharmaceutical Contract Manufacturing market revenue, by region, 2025 & 2033 (USD Million)
Figure 72 Regional marketplace: Key takeaways
Figure 73 Asia Pacific Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Japan Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 China Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 India Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 Australia Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Key country dynamics
Figure 83 South Korea Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 Thailand Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Latin America Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 Brazil Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 Argentina Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 Argentina Pharmaceutical Contract Manufacturing market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Asia-Pacific and Latin America Pharmaceutical Contract Manufacturing market report include:
  • WuXi STA
  • Piramal Pharma Solutions
  • Syngene International
  • Samsung Biologics
  • Jubilant Pharmova
  • Celltrion
  • Ajinomoto Bio-Pharma Services
  • Almac Group
  • Rubicon Research Pvt. Ltd.
  • Aurigene Pharmaceutical Services
  • Eurofarma Laboratórios S.A
  • Unither Pharmaceuticals
  • Fujifilm Diosynth Biotechnologies
  • Patheon (Thermo Fisher Scientific)
  • Pfizer

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 21.56 Billion
Forecasted Market Value ( USD ) by 2033 $ 40.71 Billion
Compound Annual Growth Rate8.3%
Regions CoveredAsia Pacific, Latin America
No. of Companies Mentioned15

Related Topics

Related Reports

Pharmaceutical Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), Product (API, Drug), Services, Workflow, Therapeutic Area, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Pharmaceutical Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), Product (API, Drug), Services, Workflow, Therapeutic Area, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 250 Pages
  • Global
From
Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type, Formulation, Application, End User, and Region 2025-2033 - Product Image

Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type, Formulation, Application, End User, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Pharmaceutical Dissolution Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2024-2033 - Product Image

Pharmaceutical Dissolution Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2024-2033

  • Report
  • 132 Pages
  • Global
From
Empty Capsules Market Size, Share, Trends and Forecast by Type, Raw Material, Functionality, Therapeutic Application, End User, and Region, 2025-2033 - Product Image

Empty Capsules Market Size, Share, Trends and Forecast by Type, Raw Material, Functionality, Therapeutic Application, End User, and Region, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.